These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17397766)

  • 1. Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions.
    Hume HA; Anderson DR
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S1-2. PubMed ID: 17397766
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions.
    Robinson P; Anderson D; Brouwers M; Feasby TE; Hume H;
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S3-8. PubMed ID: 17397767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on the use of intravenous immune globulin for hematologic conditions.
    Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R; Moltzan C; Nahirniak S; Nantel S; Pineo G; Rock G
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S9-56. PubMed ID: 17397769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current clinical uses of intravenous immunoglobulin.
    Hull JZ; Hull JH
    Clin Med (Lond); 2006; 6(5):507; author reply 507-8. PubMed ID: 17083161
    [No Abstract]   [Full Text] [Related]  

  • 6. Current clinical uses of intravenous immunoglobulin.
    El-Shanawany T; Sewell WA; Misbah SA; Jolles S
    Clin Med (Lond); 2006; 6(4):356-9. PubMed ID: 16956140
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group.
    Constantine MM; Thomas W; Whitman L; Kahwash E; Dolan S; Smith S; Caudle CJ; Burton E; Anderson DR;
    Transfusion; 2007 Nov; 47(11):2072-80. PubMed ID: 17958537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic steroids in muscular, neurologic and hematologic disorders.
    Faludi G; Dykyj R; Chayes ZW; Nodine JH
    J Am Med Womens Assoc; 1968 Apr; 23(4):346-51. PubMed ID: 4231282
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immunoglobulins in neurological diseases.
    Zettl UK; Mix E
    J Neurol; 2006 Sep; 253 Suppl 5():V1. PubMed ID: 16998748
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined use of plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Rieben R
    Ann Med Interne (Paris); 1994; 145(5):287-92. PubMed ID: 7985933
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for the use of immunoglobulin therapy for primary immune deficiency and solid organ transplantation.
    Nahirniak S; Hume HA
    Transfus Med Rev; 2010 Jan; 24 Suppl 1():S1-6. PubMed ID: 19962578
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of immunoglobulin in the therapy of neurological illnesses].
    Elovaara I; Färkkilä M; Hietaharju A; Pirttilä T
    Duodecim; 2001; 117(10):1033-41; quiz 1041, 1081. PubMed ID: 12116461
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives].
    Wintzell A; Eriksson T; Lundgren A; Petersson J
    Lakartidningen; 2008 May 21-27; 105(21):1571-5. PubMed ID: 18574994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of solumedrol in pediatrics. Apropos of 45 cases].
    Cotton JB
    Lyon Med; 1971 Feb; 225(3):251-4. PubMed ID: 5554695
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous immunoglobulin (IVIG).
    Med Lett Drugs Ther; 2006 Dec; 48(1249/1250):101-3. PubMed ID: 17149360
    [No Abstract]   [Full Text] [Related]  

  • 16. [Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins].
    Bielsa I; Benvenutti F; Guinovart RM; Ferrándiz C
    Actas Dermosifiliogr; 2012 May; 103(4):317-20. PubMed ID: 21917233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoglobulin therapy for neurologic diseases].
    Nomura K
    Nihon Naika Gakkai Zasshi; 2007 Sep; 96(9):2046-53. PubMed ID: 17929453
    [No Abstract]   [Full Text] [Related]  

  • 18. [Obsolete therapy?].
    Wuhrmann F
    Folia Clin Int (Barc); 1967 Sep; 17(9):418-20. PubMed ID: 5616120
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immune globulin.
    Med Lett Drugs Ther; 1992 Dec; 34(886):116-8. PubMed ID: 1465040
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin.
    Rey JB; Luria RB
    J Am Acad Dermatol; 2009 Jun; 60(6):1037-41. PubMed ID: 19249127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.